Sarepta Therapeutics Inc (SRPT)
132.58
-0.08
(-0.06%)
USD |
NASDAQ |
May 15, 15:58
Sarepta Therapeutics Total Return Level: 132.66 for May 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 14, 2024 | 132.66 |
May 13, 2024 | 131.70 |
May 10, 2024 | 131.82 |
May 09, 2024 | 132.30 |
May 08, 2024 | 132.58 |
May 07, 2024 | 136.04 |
May 06, 2024 | 135.04 |
May 03, 2024 | 133.66 |
May 02, 2024 | 130.63 |
May 01, 2024 | 130.90 |
April 30, 2024 | 126.66 |
April 29, 2024 | 128.80 |
April 26, 2024 | 128.77 |
April 25, 2024 | 127.39 |
April 24, 2024 | 124.25 |
April 23, 2024 | 117.12 |
April 22, 2024 | 116.96 |
April 19, 2024 | 115.62 |
April 18, 2024 | 116.55 |
April 17, 2024 | 117.89 |
April 16, 2024 | 117.29 |
April 15, 2024 | 118.31 |
April 12, 2024 | 122.87 |
April 11, 2024 | 124.45 |
April 10, 2024 | 126.31 |
Date | Value |
---|---|
April 09, 2024 | 126.98 |
April 08, 2024 | 126.39 |
April 05, 2024 | 126.08 |
April 04, 2024 | 125.79 |
April 03, 2024 | 126.92 |
April 02, 2024 | 127.00 |
April 01, 2024 | 128.40 |
March 28, 2024 | 129.46 |
March 27, 2024 | 130.23 |
March 26, 2024 | 128.25 |
March 25, 2024 | 127.94 |
March 22, 2024 | 127.54 |
March 21, 2024 | 124.94 |
March 20, 2024 | 126.08 |
March 19, 2024 | 124.06 |
March 18, 2024 | 123.97 |
March 15, 2024 | 123.05 |
March 14, 2024 | 123.76 |
March 13, 2024 | 121.96 |
March 12, 2024 | 122.00 |
March 11, 2024 | 121.58 |
March 08, 2024 | 124.37 |
March 07, 2024 | 120.78 |
March 06, 2024 | 120.31 |
March 05, 2024 | 122.85 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
62.69
Minimum
Jun 16 2022
178.74
Maximum
Dec 22 2020
109.15
Average
111.47
Median
Aug 08 2022
Total Return Level Benchmarks
PTC Therapeutics Inc | 31.18 |
Regenxbio Inc | 15.80 |
Catalyst Pharmaceuticals Inc | 16.49 |
Pfizer Inc | 98.44 |
Solid Biosciences Inc | 9.96 |